2023
Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study
Wan J, Cazer C, Clarkberg M, Henderson S, Lee S, Meredith G, Osman M, Shmoys D, Frazier P. Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study. PLOS Medicine 2023, 20: e1004153. PMID: 36626376, PMCID: PMC9876273, DOI: 10.1371/journal.pmed.1004153.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionInitial vaccination seriesPositive SARS-CoV-2 PCR testSARS-CoV-2 PCR testVaccination seriesBooster doseBooster vaccinationCohort studyStudy periodYoung adultsAcute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSyndrome coronavirus 2 infectionSevere coronavirus disease 2019Polymerase chain reaction testingCoronavirus 2 infectionRetrospective cohort studyPCR testMultivariable Poisson regressionSARS-CoV-2 variantsStatistical analysis planCoronavirus disease 2019Active surveillance approachSARS-CoV-2World Health Organization
2022
The Role of Lebanon in the COVID-19 Butterfly Effect: The B.1.398 Example
Nour D, Rafei R, Lamarca A, de Almeida L, Osman M, Ismail M, Mallat H, Berry A, Burfin G, Semanas Q, Josset L, Hassan H, Dabboussi F, Lina B, Colson P, Vasconcelos A, Hamze M. The Role of Lebanon in the COVID-19 Butterfly Effect: The B.1.398 Example. Viruses 2022, 14: 1640. PMID: 36016262, PMCID: PMC9412248, DOI: 10.3390/v14081640.Peer-Reviewed Original Research